2023: THE MEDTECH WORLD AND WHAT TO EXPECT
Green Goblin Ventures is a Malta-based legal and corporate service company specialising in the European medical cannabis industry. Co founders Chris Emms and Gianluca Caruana Curran explore Malta’s role in facilitating investment and innovation within the medical cannabis market.
Malta has wasted no time in positioning itself as a pioneer in the regulation of medical cannabis in Europe. There are very few countries in the world with such a hunger for developing innovative industries as strong as Malta’s. As such, Malta’s innovative drive has made the island an appealing destination for investment to be able to enter the European market. Malta is turning heads not only in Europe but also further afield, for its willingness to embrace the medical cannabis industry and create a highly regulated market with levels of compliance in line with the highest standards of the global pharmaceutical industry.
The Maltese Government alongside Malta Enterprise, the agency responsible for promoting and facilitating international investment in Malta, have warmly welcomed this opportunity to not only produce cannabis based products locally but to also allow for the exportation of cannabis based products, which makes for a thriving medical cannabis ecosystem.
Malta has enacted the most progressive legislation on medical cannabis in Europe which has resulted in over sixty international medical cannabis companies applying for a licence in Malta in under one year.
At Green Goblin, we have played an instrumental role in assisting several international companies to be awarded a medical cannabis license. One of the most notable companies being MPX International Corporation.
Medical Cannabis legislation in Europe is still in its early stages; as a result, the current landscape is in flux and changing rapidly. The fact that different laws apply to different territories results in uncertainty for many cannabis companies. However, we pride ourselves in being able to circumvent and tackle these issues thanks to our nimble approach to navigating the legislation and regulation.
Green Goblin offers a turnkey solution for companies who are planning to apply for a licence in Malta. We are a Malta-based legal and corporate service company specialising in the European medical cannabis industry. We offer a wide array of professional corporate, legal, and regulatory services to companies looking to expand their operations in the EU market and the surfacing medical cannabis industry
With speed-to-market being at heart of our clients’ needs we are proud of our ability to find and secure suitable industrial premises for conversion into medical cannabis facilities. This coupled with a team of qualified persons able to offer full project management and European GMP compliance is very advantageous to a prospective client.
Another pain point in the medical cannabis industry is accessing financial services. Green Goblin helps companies and ancillary businesses obtain the banking and financial services they need to be successful. This has allowed the firm to uniquely position itself as the most holistic service provider for the medical cannabis industry.
Having been the first to launch a company specifically focused on the industry in Malta and the EU has allowed for the growth of a network of high profile industry players which in turn has fostered the creation of mutual utility and cooperation between medical cannabis companies with different specialisations and local businesses interested in investment or partnership in taking definitive steps to the Maltese gateway into the European medical cannabis market.
The Medical Cannabiz World Summit will take place from the 4th to 5th November at the Intercontinental, St Julian’s, Malta, to be followed by the inaugural launch of the Medical Cannabiz World Asia Summit which will be held in Bangkok on the 22nd and 23rd of June 2020 at the Centara Grand Hotel.
Read more interviews like this in Cannabiz magazine – out now!
Dutch health-tech startup Lapsi Health raises USD 3.7M in oversubscribed Seed Round to continue their development and enter the US market